Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | 0.00% | 0.00% | +200.00% |
Apr. 22 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.35 million in funding | CI |
Apr. 12 | Universal Ibogaine Inc. announced that it expects to receive CAD 0.6 million in funding | CI |
Sales 2022 | 1.07 1.46 | Sales 2023 | 1.03 1.41 | Capitalization | 2.87M 3.93M |
---|---|---|---|---|---|
Net income 2022 | -10M -13.67M | Net income 2023 | -2M -2.73M | EV / Sales 2022 | 8,069,982 x |
Net Debt 2022 | 1.01M 1.38M | Net Debt 2023 | 2.46M 3.37M | EV / Sales 2023 | 5,181,017 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-1.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
Current month | -40.00% | ||
1 month | -40.00% | ||
3 months | +50.00% | ||
6 months | +50.00% | ||
Current year | +200.00% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
Greg J. Leavens
DFI | Director of Finance/CFO | 59 | - |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicholas Karos
CEO | Chief Executive Officer | - | 22-01-09 |
James Duncan
BRD | Director/Board Member | - | 23-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.015 | 0.00% | 94,000 |
24-04-25 | 0.015 | 0.00% | 2,060 |
24-04-24 | 0.015 | 0.00% | 39,005 |
24-04-23 | 0.015 | -25.00% | 155,000 |
24-04-22 | 0.02 | +33.33% | 2,001 |
Delayed Quote Toronto S.E., April 26, 2024 at 10:07 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+200.00% | 3.19M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- IBO Stock